Forgot your password?
Approximately 10% of all melanoma cases in the UK are diagnosed at more advanced stages
The PDE4 inhibitor is already approved in the US to treat seborrhoeic dermatitis and plaque psoriasis
Almost 77% of patients have reported that the condition negatively affects their daily activities and well-being
The precancerous condition has an estimated prevalence of 13.3% in Europe
The therapy is already approved by the regulator to treat plaque psoriasis, psoriatic arthritis and axial spondyloarthritis
Approximately 70% of patients with the inflammatory skin disease do not achieve remission with current therapies
Nystaform HC Cream is indicated to treat skin infections including ringworm and athlete’s foot
The companies have been evaluating the candidate in combination with Merck’s Keytruda
The survey revealed that half of Europe’s population gets sunburned at least once a year
The company will gain access to two atopic dermatitis treatments and other bispecific antibody programmes